The ETF closing showed mixed results, with the Hong Kong Innovative Drugs 50 ETF (513780) leading the rise at 7.27%, followed by the Hong Kong Innovative Drugs ETF (159567) at 6.57%, and the Hong Kong Stock Connect Innovative Drugs ETF (159570) at 6.44%. The New Economy ETF (159822) led the decline at 6.0%, while the S&P Biotechnology ETF (159502) dropped 2.1%, and the CNI Xiangmi Lake Fintech Index ETF (159851) fell 2.08%.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
CA
MY
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
On the first day, the Auntie in Shanghai saw oversubscription exceeding a hundred times! Hong Kong stock tea beverage stocks rose collectively.
HSBC Holdings Q1 performance exceeded expectations! Announced a buyback of up to 3 billion USD in Stocks.
The National Development and Reform Commission has issued the second batch of 81 billion yuan of ultra-long-term special government bond funds this year, continuing to strongly support the replacement of consumer goods with new ones.
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
ETF收评:港股创新药50ETF领涨7.27%,新经济ETF领跌6.0%
ETF closing review: The Hong Kong Innovative Drugs 50 ETF rose 7.27%, while the New Economy ETF fell 6.0%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 249
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report